TY - JOUR
T1 - Optimal clinical management of children receiving the ketogenic diet
T2 - Recommendations of the International Ketogenic Diet Study Group
AU - Kossoff, Eric H.
AU - Zupec-Kania, Beth A.
AU - Amark, Per E.
AU - Ballaban-Gil, Karen R.
AU - Christina Bergqvist, A. G.
AU - Blackford, Robyn
AU - Buchhalter, Jeffrey R.
AU - Caraballo, Roberto H.
AU - Helen Cross, J.
AU - Dahlin, Maria G.
AU - Donner, Elizabeth J.
AU - Klepper, Joerg
AU - Jehle, Rana S.
AU - Kim, Heung Dong
AU - Christiana Liu, Y. M.
AU - Nation, Judy
AU - Nordli, Douglas R.
AU - Pfeifer, Heidi H.
AU - Rho, Jong M.
AU - Stafstrom, Carl E.
AU - Thiele, Elizabeth A.
AU - Turner, Zahava
AU - Wirrell, Elaine C.
AU - Wheless, James W.
AU - Veggiotti, Pierangelo
AU - Vining, Eileen P.G.
AU - Anderson, Anne
AU - Cohen, Bruce
AU - Currey, Mary
AU - Donley, Diane
AU - Dure, Leon
AU - Garg, Bhuwan
AU - Goldstein, Michael
AU - Grabert, Brian
AU - Griesemer, David
AU - Kovnar, Edward
AU - Larson, Roger
AU - Legido, Agustin
AU - Morrison, Leslie Anne
AU - Parker, Colette
AU - Renfroe, J. Ben
AU - Schreck, Juergen
AU - Shinnar, Shlomo
AU - Snyder, Russell
AU - Tardo, Carmela
AU - Timmons, G. Dean
AU - Yim, Gregory
PY - 2009/2
Y1 - 2009/2
N2 - The ketogenic diet (KD) is an established, effective nonpharmacologic treatment for intractable childhood epilepsy. The KD is provided differently throughout the world, with occasionally significant variations in its administration. There exists a need for more standardized protocols and management recommendations for clinical and research use. In December 2006, The Charlie Foundation commissioned a panel comprised of 26 pediatric epileptologists and dietitians from nine countries with particular expertise using the KD. This group was created in order to create a consensus statement regarding the clinical management of the KD. Subsequently endorsed by the Practice Committee of the Child Neurology Society, this resultant manuscript addresses issues such as patient selection, pre-KD counseling and evaluation, specific dietary therapy selection, implementation, supplementation, follow-up management, adverse event monitoring, and eventual KD discontinuation. This paper highlights recommendations based on best evidence, including areas of agreement and controversy, unanswered questions, and future research.
AB - The ketogenic diet (KD) is an established, effective nonpharmacologic treatment for intractable childhood epilepsy. The KD is provided differently throughout the world, with occasionally significant variations in its administration. There exists a need for more standardized protocols and management recommendations for clinical and research use. In December 2006, The Charlie Foundation commissioned a panel comprised of 26 pediatric epileptologists and dietitians from nine countries with particular expertise using the KD. This group was created in order to create a consensus statement regarding the clinical management of the KD. Subsequently endorsed by the Practice Committee of the Child Neurology Society, this resultant manuscript addresses issues such as patient selection, pre-KD counseling and evaluation, specific dietary therapy selection, implementation, supplementation, follow-up management, adverse event monitoring, and eventual KD discontinuation. This paper highlights recommendations based on best evidence, including areas of agreement and controversy, unanswered questions, and future research.
KW - Children
KW - Consensus
KW - Diet
KW - Epilepsy
KW - Ketogenic
UR - http://www.scopus.com/inward/record.url?scp=58849155005&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=58849155005&partnerID=8YFLogxK
U2 - 10.1111/j.1528-1167.2008.01765.x
DO - 10.1111/j.1528-1167.2008.01765.x
M3 - Review article
C2 - 18823325
AN - SCOPUS:58849155005
SN - 0013-9580
VL - 50
SP - 304
EP - 317
JO - Epilepsia
JF - Epilepsia
IS - 2
ER -